Dr. Mario Saltarelli, Director of Bioasis Technologies (BTI.V) talks about the company’s ground-breaking xB3 platform which allows therapeutic drugs to pass through the seemingly impenetrable blood-brain barrier, providing an effective treatment methodology for such neurological disorders as Alzheimer’s disease, Lewy Body Dementia and Parkinson’s. In short, Bioasis’ final frontier solution could very well revolutionize medical science, potentially helping to heal the one billion people suffering from neurological disorders worldwide. Tune in!
Bioasis Technologies (BTI.V): First Glance With Jody Vance (Ep 62)
Latest Articles
- Saga Metals (SAGA.V) investors get a mature resource explorer with a ‘weak hands’ discount
- The Plurilock (PLUR.V) rip is over: But is that the end of the play?
- The unknown mining property that holds nickel copper, platinum… and uranium?
- Sparc AI: Revolutionizing Drone Technology with GPS-Free Autonomous Flight
- Skyharbour Resources (SYH.V) deserves your respect: The prospect generator that pays for itself
Top Searches
Abitibi Greenstone Belt Barrick Gold best canadian cannabis company biotech Bitcoin blockchain bullion California Canada cannabis CBD China Chris Parry covid cryptocurrency DEFN.V Fraser Institute gambling Gold gold price. gold prices Greg Nolan hemp inflation interest rates investing investments Lukas Kane marijuana mining money Newmont Goldcorp Nexus Gold pharmaceuticals psychedelics resources shrooms stock market stocks technology trading uranium wealth wealth creation weed
by
Leave a Reply